Accueil / Tag Archives: Infectious Diseases

Tag Archives: Infectious Diseases

Gilead and Galapagos Report Updated Safety Information for Filgotinib in Rheumatoid Arthritis (RA)

Thursday, March 28th 2019 at 9:02pm UTC — Pooled Interim Phase 3 FINCH Program Data up to 24 Weeks and Phase 2b DARWIN 3 Long-Term Data Add to Evidence Supporting Filgotinib Safety Profile — FOSTER CITY, Calif. & MECHELEN, Belgium–(BUSINESS WIRE)– regulated information – Gilead Sciences, Inc. (NASDAQ: GILD) and Galapagos NV (Euronext …

Plus »

Gilead and Galapagos Announce Filgotinib Meets Primary Endpoint in the Phase 3 FINCH 3 Study in Methotrexate-Naïve Rheumatoid Arthritis Patients

Thursday, March 28th 2019 at 9:04pm UTC — Filgotinib 100 mg and 200 mg Plus Methotrexate (MTX) Demonstrated Significantly Higher ACR20/50/70 Responses Than Methotrexate Alone — — Filgotinib Safety Profile Consistent With Previously Reported Results — FOSTER CITY, Calif. and MECHELEN, Belgium–(BUSINESS WIRE)– regulated information – Gilead Sciences, Inc. (NASDAQ: GILD) …

Plus »

Eccrine Systems Announces Collaboration with Maxim Integrated Products

Thursday, March 28th 2019 at 12:45pm UTC CINCINNATI–(BUSINESS WIRE)– Eccrine Systems, Inc. announced today that it is collaborating with Maxim Integrated Products, Inc. (NASDAQ: MXIM) on the development and integration of analog signal processing technologies to drive Eccrine’s sweat sensing platform. Maxim Ventures has invested in Eccrine as part of …

Plus »

HemaCare and Tissue Solutions Announce Strategic Partnership to Expand Access to Human Disease-State Samples

Thursday, March 28th 2019 at 12:10pm UTC Advancing discoveries by providing scientists with high-quality disease-state biospecimens to support preclinical and clinical research LOS ANGELES & GLASGOW, Scotland–(BUSINESS WIRE)– HemaCare Corporation (OTCMKTS: HEMA), a global leader and trusted brand in the customization of human-derived biological products and services for biomedical research, …

Plus »

Gilead Launches HepConnect Initiative to Reduce Hepatitis C Infections in Greater Appalachia

Thursday, March 28th 2019 at 9:00am UTC — Funding will Expand Testing, Harm Reduction Services and Healthcare Infrastructure in States with Highest Infection Rates — — Harm Reduction Coalition Selected as Lead Grantee to Oversee 5-year Effort to Implement Proven Harm Reduction Strategies in Indiana, Kentucky, North Carolina, Tennessee and …

Plus »

Meissa Vaccines Closes $3.4 Million Financing to Advance RSV Vaccine to Clinic

Wednesday, March 27th 2019 at 1:00pm UTC SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)– Meissa Vaccines (“Meissa”), a biotechnology company developing vaccines to prevent viral respiratory infections, announced today that it has closed a $3.4 million seed round to further develop its investigational vaccine for respiratory syncytial virus (RSV). The financing included …

Plus »

U.S. Patent Office Expands Patent Protection for Moleculera Labs’ Diagnostic Panel for Neuropsychiatric Disorders

Wednesday, March 27th 2019 at 12:00pm UTC Cunningham Panel Helps Physicians Diagnose Autoimmune-Related Neuropsychiatric Conditions including PANS/PANDAS OKLAHOMA CITY–(BUSINESS WIRE)– Moleculera Labs, Inc., an autoimmune neurobiology company, today announced that the U.S. Patent and Trademark Office (USPTO) has expanded the intellectual property protections covering the company’s Cunningham Panel (Patent No. …

Plus »

Oragenics, Inc. Enters into Collaboration with Florida International University to Expand Its Pipeline of Lantibiotics

Wednesday, March 27th 2019 at 12:00pm UTC TAMPA, Fla.–(BUSINESS WIRE)– Oragenics, Inc. (NYSE American:OGEN), a leader in the development of new antibiotics against infectious diseases and effective treatments for oral mucositis (“OM”), today announced the initiation of a collaboration with Florida International University (FIU) to create computational models of the …

Plus »

Vaxart Completes Dosing of the Lead-In Cohort in Bivalent Norovirus Vaccine Phase 1b Clinical Trial

Wednesday, March 27th 2019 at 12:00pm UTC First Oral Norovirus GII.4 Tablet Vaccine Used in Clinical Trial SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)– Vaxart, Inc., a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, today announced the completion of dosing of the lead-in …

Plus »

Gilead to Present New Data From Multiple Liver Disease Research and Development Programs at The International Liver Congress™ 2019

Wednesday, March 27th 2019 at 10:06am UTC — More Than 35 Abstracts Across NASH, PSC and Viral Hepatitis Reflect Ongoing Commitment to Advancing Liver Disease Research and Patient Care — FOSTER CITY, Calif.–(BUSINESS WIRE)– Gilead Sciences, Inc. (Nasdaq: GILD) today announced that data from the company’s research and development programs …

Plus »
>
Macbook Pro
* Intel Core i7 (3.8GHz, 6MB cache)
* Retina Display (2880 x 1880 px)
* NVIDIA GeForce GT 750M (Iris)
* 802.11ac Wi-Fi and Bluetooth 4.0
* Thunderbolt 2 (up to 20Gb/s)
* Faster All-Flash Storage (X1)
* Long Lasting Battery (9 hours)
BIENVENUE CHEZ BIOTECH FINANCES
Vous appréciez nos informations ?
Recevez nos alertes, nos dernières actualités, suivez-nous, enregistrez-vous gratuitement, rejoignez notre communauté. Merci à vous !
ARE YOU READY? GET IT NOW!
Increase more than 500% of Email Subscribers!
Your Information will never be shared with any third party.
DÉCOUVREZ LA SOLUTION STRATA !
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHBzOi8vd3d3LmJpb3RlY2gtZmluYW5jZXMuY29tL3dwLWNvbnRlbnQvdXBsb2Fkcy8yMDE1LzA3L1NhdHJhLTIubXA0IiBmcmFtZWJvcmRlcj0iMCIgYWxsb3dmdWxsc2NyZWVuPjwvaWZyYW1lPg==
Retrouvez nous sur http://stratahealth.com/fr/
Un ensemble de solutions performantes
pour assurer le continuum de vos données.
Biotech Finances
SUIVEZ-NOUS, ENREGISTREZ-VOUS !
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHA6Ly93d3cueW91dHViZS5jb20vZW1iZWQvajhsU2NITzJtTTAiIGZyYW1lYm9yZGVyPSIwIiBhbGxvd2Z1bGxzY3JlZW4+PC9pZnJhbWU+
All rights reserved © Company Name, 2014
Concours Genopole Young Biotech Award
* 100 000 € pour la meilleure Biotech
* Réservé aux biotechs hors santé
* 6 mois d'hébergement gratuit
* Un accompagnement personnalisé
* Etude de marché offerte
* Expertise du projet par EY
* Et nombre d'autres avantages...
S'inscrire au 15H BIOTECH EXPRESS
Chaque jour à 15H recevez gratuitement les news des biotechs, des medtechs,et des fonds spécialisés. Levées ; partenariats ; nominations ; fusacq ; closing ; milestone...
2019 (C) All rights reserved.

En cochant cette case, j’accepte la Politique de confidentialité de ce site et de recevoir des informations de notre part.

S'inscrire au 15H BIOTECH EXPRESS
Chaque jour à 15H recevez gratuitement les news des biotechs, des medtechs,et des fonds spécialisés. Levées ; partenariats ; nominations ; fusacq ; closing ; milestone...
2019 (C) All rights reserved.

En cochant cette case, j’accepte la Politique de confidentialité de ce site et de recevoir des informations de notre part.